TerrAscend (TSNDF) Free Cash Flow (QoQ) (2021 - 2026)
TerrAscend (TSNDF) Free Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | TerrAscend | 164.69 Mn | 164.22 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.23% |
| Dec 31, 2025 | 4,101.35% |
| Sep 30, 2025 | 116.80% |
| Jun 30, 2025 | -130.03% |
| Mar 31, 2025 | 118.48% |
| Dec 31, 2024 | -33.72% |
| Sep 30, 2024 | -67.54% |
| Jun 30, 2024 | 79.50% |
| Mar 31, 2024 | 473.19% |
| Dec 31, 2023 | -79.78% |
| Sep 30, 2023 | 55.05% |
| Jun 30, 2023 | -2.00% |
| Mar 31, 2023 | 137.30% |
| Dec 31, 2022 | -1,028.87% |
| Sep 30, 2022 | 94.84% |
| Jun 30, 2022 | -62.12% |
| Mar 31, 2022 | -155.93% |
| Dec 31, 2021 | 189.11% |
| Sep 30, 2021 | -79.40% |
| Jun 30, 2021 | -797.24% |